Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.

Pyrosequencing in picotiter plates, custom arrays for enrichment/decomplexing. (Roche)

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 12-29-2008, 08:55 PM
26 responses
63,306 views
0 likes
Last Post Guest's Avatar
by Guest
 
Started by ECO, 09-27-2008, 05:28 PM
11 responses
56,251 views
0 likes
Last Post Guest's Avatar
by Guest
 
Started by ECO, 11-05-2007, 11:40 PM
62 responses
114,048 views
0 likes
Last Post frossit
by frossit
 
Started by vs92, 07-28-2012, 09:39 AM
5 responses
6,256 views
0 likes
Last Post elizondas  
Started by Aniki, 11-04-2013, 06:49 AM
2 responses
2,878 views
0 likes
Last Post Aniki
by Aniki
 
Started by isalarubi, 11-11-2013, 05:35 AM
3 responses
2,677 views
0 likes
Last Post isalarubi  
Started by Dynamac, 11-07-2013, 10:33 AM
3 responses
2,679 views
0 likes
Last Post Dynamac
by Dynamac
 
Started by mps4208, 08-19-2013, 09:22 AM
1 response
3,005 views
0 likes
Last Post Dynamac
by Dynamac
 
Started by sinnamone, 11-05-2013, 01:52 AM
0 responses
2,199 views
0 likes
Last Post sinnamone  
Started by crndy52, 10-25-2013, 10:01 AM
2 responses
2,996 views
0 likes
Last Post sklages
by sklages
 
Started by Indiana, 11-15-2011, 10:34 AM
7 responses
4,479 views
0 likes
Last Post martin2
by martin2
 
Started by LuLuNe, 10-31-2013, 12:42 AM
1 response
2,451 views
0 likes
Last Post newmoon
by newmoon
 
Started by bbrunet, 10-25-2013, 03:33 AM
1 response
1,991 views
0 likes
Last Post flxlex
by flxlex
 
No topics found.
  • Filter
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM
  • seqadmin
    Selecting and Optimizing mRNA Library Preparations
    by seqadmin



    Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...
    08-07-2024, 12:11 PM
  • seqadmin
    Exploring the Dynamics of the Tumor Microenvironment
    by seqadmin




    The complexity of cancer is clearly demonstrated in the diverse ecosystem of the tumor microenvironment (TME). The TME is made up of numerous cell types and its development begins with the changes that happen during oncogenesis. “Genomic mutations, copy number changes, epigenetic alterations, and alternative gene expression occur to varying degrees within the affected tumor cells,” explained Andrea O’Hara, Ph.D., Strategic Technical Specialist at Azenta. “As...
    07-08-2024, 03:19 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-22-2024, 05:00 AM
0 responses
293 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-21-2024, 10:49 AM
0 responses
135 views
0 likes
Last Post seqadmin  
Working...
X